LEPU ScienTech Medical Technology (Shanghai) Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 5/6
LEPU ScienTech Medical Technology (Shanghai) has been growing earnings at an average annual rate of 35.6%, while the Medical Equipment industry saw earnings growing at 14.7% annually. Revenues have been growing at an average rate of 41.3% per year. LEPU ScienTech Medical Technology (Shanghai)'s return on equity is 11.5%, and it has net margins of 52.9%.
Wichtige Informationen
35.6%
Wachstumsrate der Gewinne
29.0%
EPS-Wachstumsrate
| Medical Equipment Wachstum der Industrie | 13.7% |
| Wachstumsrate der Einnahmen | 41.3% |
| Eigenkapitalrendite | 11.5% |
| Netto-Marge | 52.9% |
| Letzte Ertragsaktualisierung | 30 Jun 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Returns On Capital Signal Tricky Times Ahead For LEPU ScienTech Medical Technology (Shanghai) (HKG:2291)
Oct 03
There's Reason For Concern Over LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.'s (HKG:2291) Massive 36% Price Jump
Jul 03There Are Reasons To Feel Uneasy About LEPU ScienTech Medical Technology (Shanghai)'s (HKG:2291) Returns On Capital
Jun 09LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) May Have Issues Allocating Its Capital
Mar 03The Returns On Capital At LEPU ScienTech Medical Technology (Shanghai) (HKG:2291) Don't Inspire Confidence
Nov 09LEPU ScienTech Medical Technology (Shanghai) Co., Ltd.'s (HKG:2291) Shareholders Might Be Looking For Exit
Aug 14Aufschlüsselung der Einnahmen und Ausgaben
Wie LEPU ScienTech Medical Technology (Shanghai) Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 30 Jun 24 | 409 | 216 | 103 | 56 |
| 31 Mar 24 | 367 | 184 | 95 | 59 |
| 31 Dec 23 | 326 | 152 | 87 | 62 |
| 30 Sep 23 | 308 | 91 | 83 | 62 |
| 30 Jun 23 | 289 | 32 | 82 | 62 |
| 31 Mar 23 | 268 | 6 | 80 | 58 |
| 31 Dec 22 | 248 | -20 | 78 | 54 |
| 30 Sep 22 | 242 | 11 | 81 | 49 |
| 30 Jun 22 | 236 | 41 | 85 | 45 |
| 31 Mar 22 | 230 | 50 | 78 | 43 |
| 31 Dec 21 | 223 | 59 | 71 | 41 |
| 31 Dec 20 | 148 | 69 | 28 | 39 |
| 31 Dec 19 | 116 | 52 | 30 | 26 |
Qualität der Erträge: 2291 has high quality earnings.
Wachsende Gewinnspanne: 2291's current net profit margins (52.9%) are higher than last year (10.9%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: 2291's earnings have grown significantly by 35.6% per year over the past 5 years.
Beschleunigtes Wachstum: 2291's earnings growth over the past year (586.2%) exceeds its 5-year average (35.6% per year).
Erträge im Vergleich zur Industrie: 2291 earnings growth over the past year (586.2%) exceeded the Medical Equipment industry -4.3%.
Eigenkapitalrendite
Hohe Eigenkapitalrendite: 2291's Return on Equity (11.5%) is considered low.